Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

4
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
4
Diabetic Neuropathy01:22

Diabetic Neuropathy

16
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
16
Sympathetic Pathways: Sympathetic Chain Ganglia01:20

Sympathetic Pathways: Sympathetic Chain Ganglia

7.0K
The sympathetic chain ganglia, also known as the sympathetic trunk ganglia or paravertebral ganglia, are a series of ganglia located bilaterally on either side of the spinal column. These ganglia serve as relay stations for the sympathetic nervous system. Preganglionic neurons originating in the spinal cord project their axons to the sympathetic chain ganglia. Within the ganglia, these preganglionic fibers synapse with postganglionic neurons.The postganglionic neurons of the sympathetic trunk...
7.0K
Neural Regulation01:37

Neural Regulation

34.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

811
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
811
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla01:27

Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla

3.2K
The sympathetic pathways of the collateral ganglia and adrenal medulla serve unique but interconnected roles in the sympathetic response.
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene Autoleucel.

Blood cell therapy·2026
Same author

Burden of Disease in Myasthenia Gravis: A Targeted Literature Review.

Journal of neurology·2026
Same author

Smartphone-based App to Assess Diabetic Peripheral Neuropathy.

Journal of diabetes science and technology·2026
Same author

Test-retest reliability of clinical supine-to-stand tests in patients with postural orthostatic tachycardia syndrome: A cautionary tale.

Heart rhythm·2026
Same author

Smartphone-based App to Assess Diabetic Peripheral Neuropathy.

medRxiv : the preprint server for health sciences·2026
Same author

Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia.

Annals of clinical and translational neurology·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.0K

Paraneoplastic neuropathies.

Srikanth Muppidi, Steven Vernino

    Continuum (Minneapolis, Minn.)
    |October 10, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Prompt recognition of paraneoplastic neuropathies, which can present uniquely or mimic common neuropathies, may lead to early cancer detection and treatment. Management involves addressing the underlying malignancy and potentially immunomodulatory therapies.

    More Related Videos

    Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
    09:33

    Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

    Published on: August 25, 2023

    1.7K
    In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
    08:23

    In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

    Published on: April 12, 2016

    8.9K

    Related Experiment Videos

    Last Updated: Apr 22, 2026

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    3.0K
    Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
    09:33

    Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

    Published on: August 25, 2023

    1.7K
    In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
    08:23

    In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

    Published on: April 12, 2016

    8.9K

    Area of Science:

    • Neurology
    • Oncology

    Background:

    • Paraneoplastic neuropathies are rare neurological disorders associated with cancer.
    • They can present with diverse clinical manifestations, including sensory neuronopathy, autonomic neuropathy, and demyelinating neuropathy.

    Purpose of the Study:

    • To provide an approach to the recognition and management of paraneoplastic neuropathies.
    • To highlight the diagnostic challenges and therapeutic considerations for these conditions.

    Main Methods:

    • Review of existing literature on paraneoplastic neuropathies.
    • Analysis of clinical presentations, associated cancers, and treatment strategies.

    Main Results:

    • Paraneoplastic neuropathies exhibit varied phenotypes, some mimicking common polyneuropathies.
    • Specific neuropathy patterns correlate with certain cancers, though not exclusively.
    • Limited data exist on the efficacy of immunomodulatory treatments like corticosteroids and IVIg.

    Conclusions:

    • Early identification of paraneoplastic neuropathies can facilitate the diagnosis of occult malignancies.
    • Timely treatment of the underlying cancer and neuropathy may halt disease progression.